Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Biosimilar Congress 2018

About conference

The Organizing Committee is delighted to invite you to attend the 13th Biosimilars and Biologics conference, one of its remarkable pharmaceutical Conferences to be held during November 14-15, 2018 in Lisbon, Portugal. Biosimilars and Biologics Congress 2018 bring together scientists, researchers and CROs from around the world. The biosimilars market is owned to experience an exponential growth over the coming few years. The conference will also discuss Pharmacovigilance, post-marketing surveillance, and post-approval clinical studies. Compliance with regulatory guidelines is critical to the successful development and commercial launch for Biologics and Biosimilars.

At Portugal Biosimilars congress 2018 meet your target audiences from around the world focused on learning about biosimilars and biologics. This conference would be your single best opportunity to reach the largest assemblage of participants from the biosimilars and biologics community

Why to Attend???

This is your best opportunity to reach the largest assemblage of participants from biosimilars and biologics companies that is from labs, large scale industries, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries

Our Conference will provide a perfect platform addressing:

  • Commendable talks by the first-string of the global scientific community.
  • Sterling workshop sessions.
  •  Remarkable Awards and Global Recognition to meritorious Researchers.
  •  Novel Techniques to benefit your drug development
  •  Global Business and Networking Opportunities.
  •  A wide track of exhibitors to showcase the new and emerging technologies.
  •  Exquisite platform for exhibiting your by-products and International Sponsorship

Target Audience:

  •  Association, Association presidents and professionals
  • CRO and DATA management Companies
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Training Institutes
  • Software development companies
  • Noble laureates in Health Care and Medicine
  • Professors, Associate Professors, Assistant Professors
  • Business Entrepreneurs
  • Research Institutes and members
  • Chief Scientific Officers
  • Supply Chain companies
  • Directors, CEO’s of Organizations
  • Business Development Managers
  • R&D Researchers from Biosimilar and Biologics Industries
  • PhD Scholars
  • Manufacturing Companies

Sessions and Tracks

Track 1: Intellectual Property Rights

The main purpose of intellectual property law is to strengthen the production of a large variety of intellectual products. To achieve this, the law gives some businesses property rights to the people for a limited period of time. Such as patents, copyrights, industrial design rights, Trademark infringement etc. This gives economic incentive for their creation.These helpful to stimulate innovation and contribute to the technological progress of countries

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 2: Clinical Development of Biosimilars

Clinical trials which includes the preclinical, Phase I, Phase II, and Phase III trial stages. Clinical trials are designed in stages I-IV so as to receive a clear picture of the drug candidate in respect to its pharmacokinetics and pharmacodynamics parameters.some Factors are considered in clinical development include analytical methods design, study population,sample size, duration .This track includes Genotoxicity,Transgenic animals,Targeted cell line development Clinical PK/PD studies,Transgenic animals.

Suggested Conferences  Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 3: Biological Medicine

Biological medicines are work with the biology of the body and its natural healing potentiality. Disease means improper working of immune system and it need to be brought back into its natural dynamic state where the immune system is in full regulation. These biological medicines help to overcome the many diseases. These root causes may consist of several factors which have built up over time and it include diet, intestinal disturbances, food allergies, family history, stress, environmental factors, dental problems, exposure to various electromagnetic disturbances.

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 4: Present Challenges in Developing Biosimilars

The development of generic are used to overcome lot many challenges with initial steps of concepts of generics and there developments. It is very much needed that proper scientific approaches are taken for making the successful development of biologics. These biologicals are need for overcoming the challenges continues in the late clinical steps and labelling requirements. Also it is much used to develop a drug product in accordance to quality by design .This biosimilars and biologics conference will look at the multiple facets of current challenges in Biosimilars development

Suggested Conferences  Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 5: Biosimilar Market and Cost Analysis

The global biosimilar market is growing at an threatening rate. The CAGR (Compound annual growth rate) from 2016 to 2020 is projected at over 22%. The biosimilars market is going to be around $6.2 billion by 2020. At the end of this decennary the biosimilars would surely occupy 27% of the total pharmaceutical market. The estimated cost savings potential of biological products are around $54 billion over ten years .The upcoming biologics are more costly it’s about $100,000 per. However, with all the success stories there also some failure rate in manufacturing and obtaining license towards marketing of biosimilars

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 6: Biosimilars and Biologics growth in Markets

Biological medicines items are comparative as far as quality, quantity and viability to an effectively authorized reference item. The worldwide biosimilars advertise is developing quickly as licenses on blockbuster bio therapeutics terminate and other medicinal services parts centre on lessening of expenses. Biologics medicines are having more cost on the worldwide market today. In developing markets, biosimilars officially offer more moderate costs, which are beguiling, as well as crucial to economies where costly medications are not monetarily achievable

Suggested Conferences  Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 7: Analytical Strategies for Biosimilars

Analytical strategies for process improvement and acceptance and also fulfilment of generation innovations, for example, disposables and store network co-ordinations can enable organizations to build up office adaptability. This biosimilars worldwide additionally includes Bio-analytical strategies, Formulation, Bioassay for equivalence and power testing, GMP protein examination, electrophoresis, preclinical, and clinical projects.

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 8: Pharmacovigilance of Biosimilars

Pharmacovigilance is a Process of collection of safety and lesser toxic information regarding pharmaceuticals.Pharmacovigilance is the practice of observe the toxicity of medicinal drugs after they have been licensed for use, especially in order to check previously unreported adverse effects. The clinical trial data are usually not sufficient to identify rare adverse drug reactions for that general Pharmacovigilance requirements are applied to biosimilars are the same as those for any biological medicine.

Suggested Conferences  Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 9: Biosimilars- Legal Issues and BPCI Act

This track is devoted to discussion of all such cases which has been argued in the court of law. The legal issues applicable to the follow-on-biologics and biological products are one of the most aspects that require an open discussion. In the 2003 FDA had approved 36 new biologics, followed by 37 more in 2004, another 40 in 2005. By 2007, the leading category of biologic treatment, the red blood cell enhancer recombinant erythropoietin (EPO), generated $14 billion in sales revenues. More than 300 therapeutic antibodies are in clinical development and trials, compared to just 13 that are already available due to legal issues.

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums 

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden

Track 10: Biosimilar Gonadotropins

These days recombinant versions of gonadotropins are widely available and in use in IVF treatment. Various studies have been done to check if there is any clinical difference in terms of efficacy (mainly live birth rate) and safety (mainly risk of OHSS) between these modalities. Results have been ambiguous. Views of practicing clinicians on this dilemma have not yet been assessed in large scale studies. In light of this controversy, the following survey is due to assess the opinion of practicing clinicians and their rationale behind their decision-making on this topic.

Suggested Conferences   Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 11: Biopharmaceutical

Biopharmaceutical are also called medical product these Biopharmaceuticals includes blood, blood components, gene therapy, Recombinant therapeutic protein. Biopharmaceutical informatics are used in information technology, molecular modelling and biologic drug development. Development of databases containing the experimental data on biophysical stability, safety along with molecular sequence

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 12: Hybridoma technology for production of monoclonal antibodies

Hybridoma technology is methods used to producing large numbers of identical antibodies these are called monoclonal antibodies. These monoclonal antibodies are used to stimulate the patient's immune system .Alternatively, in radio immunotherapy a radioactive dose localizes on a target cell line, delivering lethal chemical doses. R&D is initiated to create antibodies for different types of diseases (such as rheumatoid arthritis, multiple sclerosis and Alzheimer’s diseases).

Suggested Conferences   Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.    

Track 13: Globalization of Biosimilars

Global uptake of Biosimilars has led to the assumption of distinct legal and regulatory frame works in different countries. This track gives information about the nonexclusive medications effect on worldwide biosimilars. And there Cost and adopting imaginative systems Economic aspect towards biosimilars. This track will look upon such key concerns which are witnessed by the global pharma market and that are coming up with the subsequent launch of the other biosimilars and biologics

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 14: Biosimilars Research Pipeline

Biosimilars are officially approved "innovative" versions of original products, and can be manufactured after the patient is expired. The biosimilars are copy of original products manufactured by different industries. The number of new drugs approvals is growing at a compounded rate of around 5% half early .Almost 1.5 times the number of biologics is expected to be in the market in 2019compared to in the last 5 years.

Suggested Conferences   Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 15: Emerging Biosimilars in Therapeutics

Biosimilars Market is experiencing a growth at an expanding rate. Presently around 700 biologics are making progress in the research pipelines of nearly 250 biopharma companies. Biosimilar insulin’s have already started remodel the future drug development in the realm of diabetology. These biosimilars are used in the rheumatic diseases and Melanoma treatment

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 16: BCS & IVIVC Based Biowaivers

To get the biowaivers BCS & IVIVC has been applied during the drug delivery in various stages of drug development, like product development and formulation screening, setting dissolution specifications. The main objective of this work is to increase the solubility, dissolution, oral absorption of water insoluble drugs. In the exponential growth, the costs and budgets of drug development, the pharmaceutical industries are difficult to find ways for saving precious resources. Nonetheless, the most critical pharmaco-economic application is the biowaivers by prevention of high priced clinical trials.

Suggested Conferences   Biosimilars Conferences | Biosimilar congress 2018 | Biologics Events | Biological Meetings

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Track 17: Drug Delivery and Development

Drug Delivery Companies and Market session is beginning to change for small, medium, and large scale pharmaceuticals ,Co-biopharmaceutical Manufacturing and Industries, generic drugs companies, contract drug delivery companies which can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of the Clinical bio therapeutics themselves

Suggested Conferences  Biosimilars conferences | Biological Conferences | Biosimilars and Biological Symposiums

11th World Microbiology & Immunology Congress June 28-29, 2018 Amsterdam, Netherlands; 12th World Congress on Biotechnology and Microbiology June 28-29, 2018 Amsterdam, Netherlands; 10th World Congress on Neuropharmacology August 28-30, 2018, Paris, France; 10th International Conference on Chemistry Education and Research June 21-22, 2018 Oslo, Norway; 5th World Congress on Physics July 17-18, 2018 Prague, Czech Republic; 14th World Congress on Pharmacology and Drug Safety August 15-17, 2018 Stockholm, Sweden; 17th Annual Congress on Pharmaceutics & Drug Delivery Systems September 20-22, 2018 Prague, Czech Republic; 8th World Congress on Chromatography September 13-14, 2018 Prague, Czech Republic; 9th Global Chemistry Congress July 23-24, 2018 Lisbon, Portugal; 5th World congress on Chemical Engineering and Catalysis August 28-30, 2018 Paris, France; 27th Euro Dentistry Congress October 25-27 2018 Prague, Czech Republic; 4th International Conference on Polymer Chemistry June 25-27, 2018 Stockholm, Sweden; 23rd Euro Congress on Dental Health and Technology June 21-22, 2018 Oslo, Norway; 14th World Congress on Gastroenterology and Hepatology June 25-27, 2018 Stockholm, Sweden.

Market Analysis

Biosimilars- biologics “biogenerics” market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a CAGR of 49.1% during the forecast period 2015 to 2020. Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. Regulations for biosimilars play a vital role in maintaining the viability and balance between original and biosimilars products. Various regulatory authorities such as EMA and FDA actively regulate the biosimilars commercialization and development.

However, biosimilars applications in autoimmune and chronic diseases exhibit the highest potential due to the changing off patent scenario. Biopharmaceutical industry is vastly dependent on the advanced technologies used in various procedures of development and manufacturing. These technologies are acting as a mandate for every single operation in biopharmaceutical and healthcare research industry. Some of the significant technologies are discussed in the report includes, Monoclonal Antibodies (MAb) Technology, Recombinant DNA Technology (rDNA technology), Nuclear magnetic resonance (NMR) technology, Chromatography, Electrophoresis, Mass Spectrometry, Western Blotting and Bioassay. Monoclonal antibody technology and bioassay technologies are the most significant technologies used in biosimilar development and validation. Based on geography, the biosimilars market is segmented across North America, Europe, Asia-Pacific and LAMEA. Asia Pacific and LAMEA exhibit a large scale demand for biosimilars due to the growing prevalence of chronic diseases in these regions.

Europe has set an example for other countries by establishing a well-worked framework for the approval of biosimilars. The U.S., with the enactment if the Affordable Care Act in 2010, also entered this market in 2015. Emerging markets, including countries in Asia, Latin America, Russia, etc., have several biosimilar products in the market since the early 2000s. The products in these countries were, however, considered inferior in quality as these countries did not have any regulatory guidelines for biosimilar approvals. Lack of any patent regulation also favoured these countries and allowed the market of biosimilars to flourish in the emerging markets. Governments of many countries have now adopted the biosimilar guidelines, encouraging the growth of global biosimilars market. Although, the acceptance of biosimilar drugs has been slow in the U.S., the recent approvals by the Food and Drug Administration (FDA) amounting to eight approvals in 2016 and 2017 in contrast to a single approval in 2015, show that the trend towards biosimilars in the developed world is gaining traction. 

                                                                           

A number of factors such as growing pressure to curtail healthcare expenditure, growing demand of biosimilar drugs due to their cost effectiveness, rising incidences of various diseases, increasing number of off-patented drugs, positive outcome in the on-going clinical trials, and rising demand for biosimilars in different therapeutic applications such as rheumatoid arthritis and blood disorders are propelling the growth of the global market

Biosimilars Market Projected To Reach $41.7 Billion By 2024

Biosimilars Market, by Product (Revenue, USD Million, 2017 - 2024)

  • Recombinant Non-Glycosylated Proteins
    • Insulin
    • Human Growth Hormones
    • Granulocyte Colony-stimulating Factor (G-CSF)
    • Interferons
  • Recombinant Glycosylated Proteins
    • Erythropoietin
    • Monoclonal Antibodies
    • Follitropin

Biosimilars Market, by Application (Revenue, USD Million, 2017 - 2024)

  • Oncology
  • Blood Disorders
  • Growth Hormone Deficiency
  • Chronic and Autoimmune Disorders
  • Others

Biosimilars Market, by Region (Revenue, USD Million, 2017 - 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany

Past Conference Report

Biosimilars-euro 2017
Conference Series hosted the 7th European Biosimilars Congress at Novotel Munchen City Arnulfpark Munich, Germany during May 15-16, 2017.The conference was designed around the theme of “The developmental strategies and uptake of biosimilars through a decade in Europe” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.

Euro Biosimilars 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilar.

Conference Series would like to convey a warm gratitude to all the Honourable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Euro Biosimilars 2017.

Christoph Volpers, Michalski & Hüttermann, Germany

Arthur G Cook, ZS Associates, USA

Tim Demuth, Sandoz Pharmaceuticals GmbH, Germany

Rosa Helena Bustos, University of La Sabana, Colombia

Ulrike Konrad, Protagen Protein Services , Germany

Stanley Seung Suh Hong, Celltrion Healthcare Co. Ltd., South Korea

Ulrich Storz, Michalski Huttermann & Partner, Germany

We on behalf of the conference specially thank the exhibitors for their participation in the congress and also the media partners for their wonderful marketing of the event. Conference Series also took the privilege of felicitating Euro Biosimilars 2017 Organizing Committee, Keynote Speakers and Chair whose support made conference a great success.

With the enormous feedback from the participants and supporters of Euro Biosimilars 2017, we are glad to announce 13thInternational Conference on Biosimilars and Biologics  during November 14-15, 2018 in Lisbon, Portugal

                            See you next year at Lisbon,Portugal

For More details visit:  https://biosimilars.annualcongress.com/

 

 

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Bioanalysis & Biomedicine Journal of Bioequivalence & Bioavailability Journal of Pharmaceutical Sciences & Emerging Drugs

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Abbreviated Clinical Trial Designs
  • Analytical Strategies For Biosimilars
  • BCS Based Biowaivers
  • Bio Similar Innovative Devices
  • Bioequivalence Assessment
  • Biological Licenses
  • Biosimilar Companies
  • Biosimilar Cost Analysis
  • Biosimilar Manufacturer Strategies
  • Biosimilar Market
  • Biosimilar Medicines
  • Biosimilar Product Development
  • Biosimilars And Biologics
  • Biosimilars And Their Social Repercussions
  • Biosimilars Approved In Europe
  • Biosimilars Approved In US
  • Biosimilars Economic Predictions
  • Biosimilars In Developing Countries
  • Biosimilars Manufacturing Process
  • Biosimilars Research Pipeline
  • Challenges In Biosimilars Pharmacovigilance
  • Clinical Development Of Biosimilars
  • Commercial Landscape In Biosimilars
  • Comparison Of Biologic Drug Prices
  • Consequences Of Brexit On Biosimilars
  • Current Challenges In Developing Biosimilars
  • Differences Between Biosimilars And Generic Drugs
  • Emerging Biosimilars In Therapeutics
  • Fingerprinting Analysis
  • Future Of Biosimilars
  • Globalization Of Biosimilars
  • Health Technology Assesment Of Biosimilars
  • Innovative Approach For Biosimilars
  • Intellectual Property Rights
  • Interchangeability Of Biosimilars
  • Investigator Initiated Biosimilar Research
  • IVIVC Based Biowaivers
  • Laws On Biologics Regulation
  • Legal Issues And BPCI Act
  • Market Analysis Of Biosimilars
  • Need For Biosimilars
  • New Pathway For Biosimilars
  • Outlook On Biosimilars
  • Patient Safety In Biosimilars
  • Quality Considerations For Biosimilars Biosimilars
  • Reimbursement And Coding In Biosimilars
  • Stability Of Biosimilars
  • Substitution Of Biosimilars
  • The Savings Potential Of Biosimilars
  • Therapeutic Efficiency Of Biosimilars
  • What Are MAbs Biosimilars?
  • What Is A Biologic Medicine?
  • What Is A Biosimilar Medicine?
  • Worldwide Regulatory Status Of Biosimilars